Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake

American Journal of Hematology

Volumn 83, Issue 6, 2008, Pages 437-445

  Poulsen, Raewyn C ^a   Gotlinger, Katherine H ^b,c   Serhan, Charles N ^b,c   Kruger, Marlena C ^a,d  

^a MASSEY UNIVERSITY   (New Zealand)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^d MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CD59 ANTIGEN; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; LIPID; LIPOXIN; LIPOXYGENASE; OMEGA 3 FATTY ACID; PROTECTIN D1; RESOLVIN; RESOLVIN D1; RESOLVIN E1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; BONE MARROW; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; GAS CHROMATOGRAPHY; IN VIVO STUDY; INFLAMMATION; LIPID COMPOSITION; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; BONE MARROW; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; INFLAMMATION; LIPID METABOLISM; LIPIDS; LIPOXINS; LIPOXYGENASE; MASS SPECTROMETRY; OVARIECTOMY; RATS;

EID: 44349165015     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21170     Document Type: Article

References (67)

1. Serhan CN, Clish CB, Brannon J, et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000;192:1197-1204.
2. Serhan CN, Hong S, Gronert K, et al. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002;196:1025-1037.
3. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005;73:141-162.
4. Bannenberg G, Moussignac RL, Gronert K, et al. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br J Pharmacol 2004;143:43-52,
5. Bannenberg GL, Chiang N, Ariel A, et al. Molecular circuits of resolution: Formation and actions of resolvins and protectins. J Immunol 2005;174:4345-4355.
6. Serhan CN, Gotlinger K, Hong S, et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: An overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 2004;73:155-172.
7. Weller CL, Collington SJ, Brown JK, et al. Leukotriene B-4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med 2005;201:1961-1971.
8. Chung JW, Kim GY, Mun YC, et al. Leukotriene B-4 pathway regulates the fate of the hematopoietic stem cells. Exp Mol Med 2005;37:45-50.
9. Lacey DL, Erdmann JM, Teitelbaum SL, et al. Interleukin-4, interferon-γ, and prostaglandin-E impact the osteoclastic cell-forming potential of murine bone-marrow macrophages. Endocrinology 1995;136:2367-2376.
10. Collins DA, Chambers TJ. Effect of prostaglandins-E1, E2, and F2-α on osteoclast formation in mouse bone-marrow cultures. J Bone Miner Res 1991;6:157-164.
11. Jagels MA, Hugli TE. Neutrophil chemotactic factors promote leukocytosis - A common mechanism for cellular recruitment from bone-marrow. J Immunol 1992;148:1119-1128.
12. Wada K, Arita M, Nakajima A, et al. Leukotriene B-4 and lipoxin A(4) are regulatory signals for neural stem cell proliferation and differentiation. FASEB J 2006;20:1785-1792.
13. Fischer CP, Berntsen A, Perstrup LB, et al. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 2007;17:580-587.
14. Nakamura Y, Ueno Y, Tamaki S, et al. Fish consumption and early atherosclerosis in middle-aged men. Metabolism 2007;56:1060-1064.
15. Cauley JA, Danielson ME, Boudreau RM, et al. Inflammatory markers and incident fracture risk in older men and women: The health aging and body composition study. J Bone Miner Res 2007;22:1088-1095.
16. Chung HY, Sung B, Jung KJ, et al. The molecular inflammatory process in aging. Antioxidants Redox Signaling 2006;8:572-581.
17. De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005;146:4192-4199.
18. Schulze MB, Hoffmann K, Manson JE, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 2005;82:675-684.
19. Blasko I, Stampfer-Kountchev M, Robatscher P, et al. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: The role of microglia and astrocytes. Aging Cell 2004;3:169-176.
20. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women - A randomized trial. JAMA 2003;289:1799-1804.
21. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001;8:131-136.
22. Dasilva J, Peers S, Perretti M, et al. Sex steroids affect glucocorticoid response to chronic inflammation and to interleukin-1. J Endocrinol 1993;136: 389-397.
23. Seale JV, Wood SA, Atkinson HC, et al. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J Neuroendocrinol 2004;16:989-998.
24. Björntorp P. Alterations in the Ageing Corticotropic Stress-Response Axis. Novartis Foundation Symposium 242, Endocrine Facets of Ageing. West Sussex: Wiley; 2002.
25. Blackwell GJ, Carnuccio R, Dirosa M, et al. Macrocortin - A polypeptide caus-ing the anti-phospholipase effect of glucocorticoids. Nature 1980;287:147-149.
26. Masferrer J, Seibert K, Zweifel B, et al. Endogenous glucocorticoids regulate an inducible cyclooxgenase. Proc Natl Acad Sci USA 1992;89:3917-3921.
27. Goppelt-Struebe M, Wolter D, Resch K. Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclooxygenase/PGE isomerase. Br J Pharmacol 1989;98:1287-1295.
28. Fisch B, Rose MP, Elder MG, et al. Effects of estrogen on progesterone synthesis and arachidonic acid metabolism in human luteal cells. Clin Endocrinol 1994;40:21-32.
29. Ham E, Cirillo V, Zanetti M, et al. Estrogen-directed synthesis of specific prostaglandins in uterus. Proc Natl Acad Sci USA 1975;72:1420-1424.
30. Blackwell GJ, Carnuccio R, Dirosa M, et al. Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal-cavity of the rat. Br J Pharmacol 1982;76:185-194.
31. Masuzawa T, Miyaura C, Onoe Y, et al. Estrogen deficiency stimulates B-lymphopoiesis in mouse bone marrow. J Clin Invest 1994;94:1090-1097.
32. Erben RG, Raith S, Eberle J, et al. Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow. Am J Physiol 1998;37:E476-E483.
33. Shevde NK, Pike JW. Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis. Blood 1996;87:2683-2692.
34. Feyen JHM, Raisz LG. Prostaglandin production by calvariae from sham operated and oophorectomized rats - Effect of 17-β-estradiol in vivo. Endocrinology 1987;121:819-821.
35. Maccarrone M, Bari M, Battista N, et al. Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood 2002;100:4040-4048.
36. Kawaguchi H, Pilbeam CC, Vargas SJ, et al. Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest 1995;96:539-548.
37. Carlsten H. Immune responses and bone loss: The estrogen connection. Immunol Rev 2005;208:194-206.
38. Sites CK, Toth MJ, Cushman M, et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002;77:128-135.
39. Bismar H, Diel I, Ziegler R, et al. Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 1995;80:3351-3355.
40. Watkins BA, Shen CL, Allen KGD, et al. Dietary (n-3) and (n-6) polyunsaturates and acetylsalicylic acid alter ex vivo PGE(2) biosynthesis, tissue IGF-1 levels, and bone morphometry in chicks. J Bone Miner Res 1996;11:1321-1332.
41. Profita M, Vignola AM, Sala A, et al. Interleukin-4 enhances 15-lipoxygenase activity and incorporation of 15(S)-HETE into cellular phospholipids in cultured pulmonary epithelial cells. Am J Respir Cell Mol Biol 1999;20:61-68.
42. Gross E, Ruzicka T, Vonrestorff B, et al. High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-Hete) in a human epidermal-cell line. J Invest Dermatol 1990;94:446-451.
43. Traianedes K, Dallas MR, Garrett IR, et al. 5-Lipoxygenase metabolites inhibit bone formation in vitro. Endocrinology 1998;139:3178-3184.
44. Mayser P, Mrowietz U, Arenberger P, et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998;38:539-547.
45. Yokoyama A, Hamazaki T, Ohshita A, et al. Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma. Int Arch Allergy Immunol 2000;123:327-332.
46. Nagakura T, Matsuda S, Shichijyo K, et al. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000;16:861-865.
47. Kruger M, Coetzer H, de Winter R, et al. Calcium, γ-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging Clin Exp Res 1998;10:385-394.
48. Kruger M, Claassen N, Schlemmer C, et al. Essential fatty acid supplementation: Effect on oestrogen deficiency induced bone loss in the female rat. Calcif Tissue Int 1999;64:63.
49. Watkins BA, Li Y, Seifert MF. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: Actions on bone mineral and serum biomarkers in ovariectomised rats. J Nutr Biochem 2006;17:282-289.
50. Ashton I, Clements K, Barrow SE, et al. Effects of dietary fatty-acids on eicosanoid-generating capacity, fatty-acid composition and chemotactic activity of rainbow-trout (Oncorhynchus-mykiss) leukocytes. Biochim Biophys Acta 1994;1214:253-262.
51. Gonzalez-Periz A, Palanaguma A, Gronert K, et al. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: Protectin D1 and 17S-hydroxy-DHA. FASEB J 2006;20:2537-2539.
52. Gerster H. Can adults adequately convert α-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res 1998;68:159-173.
53. Poulsen RC, Kruger MC. Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids 2006;75:419-427.
54. Kruger MC, Scholium LM. Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability? Prostaglandins Leukot Essent Fatty Acids 2005;73:327-334.
55. Bathija A, Davis S, Trubowitz S. Bone marrow adipose tissue: Response to acute starvation. Am J Hematol 1979;6:191-198.
56. Ariel A, Li P-L, Wang W, et al. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem 2005;280:43079-43086.
57. Mukherjee PK, Marcheselli VL, Serhan CN, et al. Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 2004;101:8491-8496.
58. Hasturk H, Kantarci A, Ohira T, et al. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J 2005; 19:401-403.
59. Duffield J, Hong S, Vaidya V, et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006;177:5902-5911.
60. Arita M, Yoshida M, Hong S, et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA 2005; 102:7671-7676.
61. Marcheselli VL, Hong S, Lukiw WJ, et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003;278:43807-43817.
62. Teggatz EG, Hong S, Siebenaler JF, et al. Mechanism mediating the action of omega-3 PUFA: Potent coronary vasodilation of resolvins, novel docosanoids. FASEB J 2004;18:A981-A981.
63. Lukiw WJ, Cui JG, Marcheselli VL, et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005;115:2774-2783.
64. National Research Council. Nutrient Requirements of Laboratory Animals Fourth Revised Edition. Washington DC: National Academy Press; 1995. 65. James K, Butts C, Hardacre A, et al. The effect of drying room temperature on the nutritional quality of New Zealand-grown maize for growing rats. J Sci Food Agric 2004;84:147-157.
65. Scutt A, Reading L, Scutt N, et al. Mineralizing fibroblast-colony- forming assays. In: Helfrich M,Ralston S, editors. Methods in Molecular Medicine, Bone Research Protocols, Vol. 80. Totowa, NJ: Humana Press; 2003. pp 29-39.
66. Lu Y, Hong S, Gotlinger K, et al. Lipid mediator informatics and proteomics in inflammation-resolution. Sci World J 2006;6:589-614.
67. Hong S, Lu Y, Yang R, et al. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J Am Soc Mass Spectrom 2007;18:128-144.